Results 11 to 20 of about 3,242,059 (273)
Comparison of the performance of three cancer antigen (CA) 15-3 immunoassays
Journal of Health Sciences, 2016 Introduction: In the present study we investigated the performance, precision, and recovery of three different automated methods in determining cancer antigen (CA) 15-3 levels. Methods: Serum samples were obtained from 60 hospitalized female patients. As
Nafija Serdarevic +2 more
doaj +3 more sources
Let-7b microRNA and Sirtuin-1 mRNA gene expression as potential biomarkers for breast cancer Egyptian patients [PDF]
Ain Shams Medical Journal, 2023 Background and objectivesThe most frequently detected life-threatening malignancy in women is breast cancer. We aimed to evaluate Sirtuin-1 mRNA and let-7b microRNA gene expression in breast cancer patients in Egypt and to relate them with ...
Moatez Kamel +5 more
doaj +2 more sources
New Quantum-Dot-Based Fluorescent Immunosensor for Cancer Biomarker Detection
Chemosensors, 2022 Cancer antigen 15-3 (CA 15-3) is a biomarker for breast cancer used to monitor response to treatments and disease recurrence. The present work demonstrates the preparation and application of a fluorescent biosensor for ultrasensitive detection of the ...
Mariana P. Sousa +5 more
doaj +1 more source
Correlation between CA-15-3 and Bone Scan findings in patients with Carcinoma Breast
Asian Pacific Journal of Cancer Biology, 2022 Objectives: Breast cancer is the most common malignant tumor of females; the incidence increases with age. Bone is the most common site to which breast cancer metastasizes.
Julekha Khatun, Tarim Mahmood
doaj +1 more source
Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. [PDF]
Dis Markers, 2014 CA 15-3, CA 125 and β-2 microglobulin are three common tumor markers currently used for diagnosis, prognosis, assessment of therapeutic response, and/or to evaluate recurrence in breast and ovarian cancer and malignant lymphoproliferative disorders ...
Lucarelli G +11 more
europepmc +4 more sources
Diagnostics, 2023 Tumor marker determinations are valuable tools for the guidance of breast cancer patients during the course of disease. They are assessed on diverse analytical platforms that may be associated with differences according to the methods applied and the ...
Lars Schröder +9 more
doaj +1 more source
Clinical usefulness of cancer markers in primary breast cancer [PDF]
, 2011 The aim of this study was to investigate the diagnostic power of CA 549, MSA and CA 15-3 in identifying breast cancer. The study included 232 patients of which 56 were healthy, 43 had benign breast cancer and 191 with other growths.
Verring, A. +3 more
core +1 more source
Case Reports in Oncology, 2021 A 73-year-old woman with no history of disease was referred to our hospital with fatigue and joint pain. Screening blood test showed that her cancer antigen 15-3 (CA 15-3) serum level was elevated to 36.6 U/mL, and a contrast-enhanced computed tomography
Koichiro Takayama +4 more
doaj +1 more source
Cancer Treatment and Research Communications, 2021 Background: We aimed to evaluate the association of serum carcinoembryonic antigen (CEA) and cancer antigen 15–3 (CA 15–3) levels with clinicopathological parameters in patients with breast cancer (BC) and their efficiency for the prediction of ...
Meliha Melin Uygur, Mahmut Gümüş
doaj +1 more source
Clinical validation of the novel CLIA-CA-62 assay efficacy for early-stage breast cancer detection
Frontiers in Oncology, 2023 BackgroundWithout organized screening programs up to 60-70% of breast cancers are diagnosed at advanced stages that have significantly lower five-year survival rate and poorer outcomes, which is a serious global public health problem.
Marina Sekacheva +4 more
doaj +1 more source